These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17726467)

  • 1. PLD1 is overexpressed in an ER-negative MCF-7 cell line variant and a subset of phospho-Akt-negative breast carcinomas.
    Gozgit JM; Pentecost BT; Marconi SA; Ricketts-Loriaux RS; Otis CN; Arcaro KF
    Br J Cancer; 2007 Sep; 97(6):809-17. PubMed ID: 17726467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
    Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
    Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc.
    Rodrik V; Zheng Y; Harrow F; Chen Y; Foster DA
    Mol Cell Biol; 2005 Sep; 25(17):7917-25. PubMed ID: 16107734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of an aggressive MCF-7 cell line variant, TMX2-28, to study cell invasion in breast cancer.
    Gozgit JM; Pentecost BT; Marconi SA; Otis CN; Wu C; Arcaro KF
    Mol Cancer Res; 2006 Dec; 4(12):905-13. PubMed ID: 17189381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells.
    Kang DW; Park MH; Lee YJ; Kim HS; Lindsley CW; Alex Brown H; Min do S
    Int J Cancer; 2011 Feb; 128(4):805-16. PubMed ID: 20473892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of melanogenesis by phospholipase D1 through mTOR/p70 S6 kinase 1 signaling in mouse B16 melanoma cells.
    Ohguchi K; Banno Y; Nakagawa Y; Akao Y; Nozawa Y
    J Cell Physiol; 2005 Dec; 205(3):444-51. PubMed ID: 15895362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple negative breast cancer: a study from the point of view of basal CK5/6 and HER-1.
    Pintens S; Neven P; Drijkoningen M; Van Belle V; Moerman P; Christiaens MR; Smeets A; Wildiers H; Vanden Bempt I
    J Clin Pathol; 2009 Jul; 62(7):624-8. PubMed ID: 19561231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
    Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
    Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway: therapeutic implications for combination therapy with rapamycin.
    Dragowska WH; Verreault M; Yapp DT; Warburton C; Edwards L; Ramsay EC; Huxham LA; Minchinton AI; Gelmon K; Bally MB
    Breast Cancer Res Treat; 2007 Dec; 106(3):319-31. PubMed ID: 17347776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of breast cancer cell lines by a low-density microarray.
    de Longueville F; Lacroix M; Barbuto AM; Bertholet V; Gallo D; Larsimont D; Marcq L; Zammatteo N; Boffe S; Leclercq G; Remacle J
    Int J Oncol; 2005 Oct; 27(4):881-92. PubMed ID: 16142302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
    Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
    Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective estrogen receptor (ER) modulators differentially regulate phospholipase D catalytic activity in ER-negative breast cancer cells.
    Eisen SF; Brown HA
    Mol Pharmacol; 2002 Oct; 62(4):911-20. PubMed ID: 12237338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumour proliferation and oestrogen receptor status.
    Jares P; Rey MJ; Fernández PL; Campo E; Nadal A; Muñoz M; Mallofré C; Muntané J; Nayach I; Estapé J; Cardesa A
    J Pathol; 1997 Jun; 182(2):160-6. PubMed ID: 9274525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation.
    Noble AR; Maitland NJ; Berney DM; Rumsby MG
    Br J Cancer; 2018 Jan; 118(2):189-199. PubMed ID: 29136407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of phospholipase D1 in the regulation of mTOR activity by lysophosphatidic acid.
    Kam Y; Exton JH
    FASEB J; 2004 Feb; 18(2):311-9. PubMed ID: 14769825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.
    Cao MD; Döpkens M; Krishnamachary B; Vesuna F; Gadiya MM; Lønning PE; Bhujwalla ZM; Gribbestad IS; Glunde K
    NMR Biomed; 2012 Sep; 25(9):1033-42. PubMed ID: 22279038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype.
    Carmeci C; Thompson DA; Kuang WW; Lightdale N; Furthmayr H; Weigel RJ
    Surgery; 1998 Aug; 124(2):211-7. PubMed ID: 9706140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas.
    Bièche I; Girault I; Sabourin JC; Tozlu S; Driouch K; Vidaud M; Lidereau R
    Br J Cancer; 2003 Mar; 88(6):863-70. PubMed ID: 12644823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of oestrogen receptor expression in breast cancer by quantification of mRNA.
    Potemski P; Pluciennik E; Bednarek AK; Kusinska R; Kubiak R; Kordek R
    Histopathology; 2007 Dec; 51(6):829-36. PubMed ID: 18042072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.